T lymphocyte and B lymphocyte
T lymphocyte develop
from bone marrow-derived cells that migrate to the thymus .
They are essential to
human defense against infectious organisms and some cancers. There are two main types of T-cells: helper
T-cells and killer T-cells. Helper T-cells stimulate B-cells to make antibodies
and help killer cells develop. Killer T-cells directly kill cells that
have already been infected by a foreign invader. T-cells also use
cytokines as messenger molecules to send chemical instructions to the rest of
the immune system to ramp up its response. Activating T-cells against cancer
cells is the basis behind checkpoint inhibitors, a relatively new class of
immunotherapy drugs that have recently been federally approved to treat lung
cancer, melanoma and other difficult cancers. Cancer cells often evade
patrolling T-cells by sending signals that make them seem harmless. Checkpoint
inhibitors disrupt those signals and prompt the T-cells to attack the cancer
cells.
B lymphocyte
B cells, also known as B lymphocytes, are a
type of white blood cell of the lymphocyte subtype.
They function in the humoral
immunity component of the adaptive immune
system by secreting antibodies.
Additionally, B cells present
antigens (they are also classified as professional antigen-presenting
cells (APCs)) and secrete cytokines
In mammals, B
cells mature in the bone marrow, which is at the core of
most bones.
In birds, B cells mature in
the bursa of Fabricius, a lymphoid organ where they were first discovered
by Chang and Glick, (B for bursa) and not from bone marrow as commonly
believed.
B cells, unlike the other two classes of
lymphocytes, T cells and natural killer cells, express B
cell receptors (BCRs) on their cell membrane
BCRs allow the B cell to bind to
a specific antigen, against which it will initiate an antibody response
While both are critical to the body's defense against disease
and infection, T-cells and B-cells play very different roles. CART therapy and
checkpoint inhibitors are examples of how researchers are using what they’ve
learned about T-cells specifically in developing new cancer treatments. But as
their differences and similarities show, both types of immune cells employ
important natural defenses in helping the body fight cancer.
Summary of T Lymphocyte and B lymphocyte
topic | T lymphocyte | B lymphocyte |
Origin | Bone marrow | Bone marrow |
Mature | Thymus | Bone marrow |
Location of mature cell | Mature cell present within the lymph node | Mature cell present out side the lymph node |
Receptors | Bear TCR receptors | Bear BCR receptor |
Viral antigens | Recognized viral antigens on the outside of infected cells | Recognized antigens on the surface of bacteria and viruses |
Life span | Long | Short |
Type of immunity | Cell mediated immunity | Humoral or Antibodies mediated immunity |
Types of active cell | Cytotoxic T cell , Helper T cell and suppressor / regulatory T cells and memory cells | Plasma cell and memory cells |
Surface antigens | Lack of surface antigen | Have surface antigen |
Secrete | Lymphokines | Antibodies |
% | 80% are T lymphocyte | 20% are B lymphocyte |
Site of infection | Move to the site of infection | Does not move to the site of infection |
Tumor cell | Act against tumor cell or transplant | Do not act against tumor cell or transplant |
Effect on immune system | Inhibitory effect on immune system | No inhibitory effect on immune system |
Functions | · Lyse virus infected cells and cancer cells · Provides immunity against most viruses and few bacteria · Aid B cell in antibodies production · Modulate immune response | Help eliminate free foreign invaders by enhancing innate immune responses against them Provide immunity against most bacteria and few viruses |
No comments:
Post a Comment